Search

Search Constraints

You searched for: Author/Creator Ganser, Arnold

Search Results

1. A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations. (29th March 2015)

2. A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia. (9th June 2020)

3. Accurate quantification of chromosomal lesions via short tandem repeat analysis using minimal amounts of DNA. Issue 9 (9th June 2017)

4. Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation. (26th July 2015)

5. Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced‐intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT. (12th September 2021)

7. Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial. Issue 3 (18th February 2020)

8. Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia. (20th October 2022)

9. Comparative outcomes of myeloablative and reduced‐intensity conditioning allogeneic hematopoietic cell transplantation for therapy‐related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation. Issue 4 (10th January 2019)

10. Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with acute myeloid leukemia with normal karyotype. (November 2017)